Nu Skin Enterprises (NYSE:NUS) Updates Q1 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its first quarter 2025 earnings guidance on Thursday. The company provided EPS guidance of 0.100-0.200 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $345.0 million-$365.0 million, compared to the consensus revenue estimate of $404.6 million. Nu Skin Enterprises also updated its FY 2025 guidance to 0.900-1.300 EPS.

Wall Street Analysts Forecast Growth

NUS has been the topic of several recent research reports. DA Davidson reduced their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. Citigroup dropped their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research note on Tuesday, October 22nd. Finally, StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th.

Nu Skin Enterprises Trading Up 1.3 %

Shares of NYSE NUS traded up $0.09 during trading hours on Thursday, hitting $6.41. The company’s stock had a trading volume of 1,274,980 shares, compared to its average volume of 687,085. Nu Skin Enterprises has a 12 month low of $5.95 and a 12 month high of $17.68. The stock has a market cap of $318.40 million, a price-to-earnings ratio of -3.09 and a beta of 1.17. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The business has a 50-day simple moving average of $6.91 and a 200-day simple moving average of $7.50.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. On average, analysts anticipate that Nu Skin Enterprises will post 0.68 earnings per share for the current fiscal year.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.